Advantage Alpha Capital Partners LP Harrow Health, Inc. Transaction History
Advantage Alpha Capital Partners LP
- $299 Million
- Q3 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 111,553 shares of HROW stock, worth $4.54 Million. This represents 1.76% of its overall portfolio holdings.
Number of Shares
111,553Holding current value
$4.54 Million% of portfolio
1.76%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
218Shares Held
21.4MCall Options Held
998KPut Options Held
593K-
Opaleye Management Inc. Boston, MA3.91MShares$159 Million30.67% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$87.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$76.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.86MShares$75.6 Million9.42% of portfolio
-
State Street Corp Boston, MA794KShares$32.4 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.1B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...